Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
10/08/2003 | CN1123639C Human activated protein C and its prepn. process |
10/07/2003 | US6631329 Use of the crystal structure of Staphylococcus aureus isoleucyl-tRNA synthetase in antibiotic design |
10/07/2003 | US6630617 Enzymes involved in squalene metabolism |
10/07/2003 | US6630615 Plants; gene expression; promoters; neoxanthin cleavage enzyme activity; genetic engineering; use of isolated nucleotide sequences to transform plants with genes that will enhance the resistance of the plants to diseases |
10/07/2003 | US6630613 Mouse whose genome comprises a disruption of large tumor suppressor (lats) protein; use in treatment of cancer and hyperproliferative disorders; use antagonists in growing larger animals and plants |
10/07/2003 | US6630582 Isolated nucleic acid, of given sequence, which encodes a catalase; gastroduodenal diseases |
10/07/2003 | US6630572 Thrombin derived polypeptides: compositions and methods for use |
10/07/2003 | US6630347 Endothelial NOS transgenic animals and methods of use |
10/07/2003 | US6630342 Biopreparation of textiles at high temperatures |
10/07/2003 | US6630341 Phosphohexuloisomerase and gene therefor |
10/07/2003 | US6630340 Xyloglucanases belonging to family 5 of glycosyl hydrolases are derived from strains of paenibacillus, the xyloglucanases show high performance in conventional liquid detergent |
10/07/2003 | US6630339 Of given amino acid sequence; use in production of deantigenated erythrocytes (conversion of type B to type O); blood tranfusions |
10/07/2003 | US6630338 Aggregation, precipitation using surfactant |
10/07/2003 | US6630337 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
10/07/2003 | US6630336 Peptides; for use as tools in human therapeutics and diagnostic testing |
10/07/2003 | US6630335 14171 protein kinase, a novel human protein kinase and uses thereof |
10/07/2003 | US6630334 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
10/07/2003 | US6630333 Permeabilizing a bacterial cell; filtration; free of nucleic acids and other contaminants |
10/07/2003 | US6630332 Process for the fermentative preparation of L-threonine |
10/07/2003 | US6630331 Isolated DNA encoding a protein from Lotus japonicus which has pantothenate synthetase activity; enzyme inhibitors |
10/07/2003 | US6630330 Ascorbic acid production from yeast |
10/07/2003 | US6630324 Aldehyde reductase bidirectional promoter and its use |
10/07/2003 | US6630319 Containing a proof-reading function; chimeric enzyme; Pyrococcus and Thermus; useful in primer extension techniques, nucleic acid sequencing and amplification |
10/07/2003 | US6630305 Compositions and methods for the therapy and diagnosis of prostate cancer |
10/07/2003 | US6630139 Fibrinogenolytic proteases with thrombolytic and antihypertensive activities: medical application and novel process of expression and production |
10/07/2003 | US6630138 Protein C derivatives |
10/07/2003 | CA2107105C Heterocyclic-cyclic amine derivatives |
10/07/2003 | CA2076320C Process for producing peptide |
10/07/2003 | CA1341443C Human c3b/c4b receptor (cr1) (the) |
10/02/2003 | WO2003080873A1 Cleaning animal skins |
10/02/2003 | WO2003080855A2 Deracemisation of amines |
10/02/2003 | WO2003080848A1 Biobeads having foreign genetic substance immobilized to calcium alginate |
10/02/2003 | WO2003080844A2 Enhancement of vitamin e content in organisms by enhancing 2-methyl-6-phytyl hydroquinone-methyltransferase activity |
10/02/2003 | WO2003080843A1 Method for l-threonine production |
10/02/2003 | WO2003080842A1 Zearalenone-detoxifying enzyme gene and transformant having the gene transferred thereinto |
10/02/2003 | WO2003080836A1 Nerve regeneration genes |
10/02/2003 | WO2003080833A1 Xanthosine methylase and use thereof |
10/02/2003 | WO2003080832A1 Candida utilis containing ϝ-glutamylcysteine |
10/02/2003 | WO2003080827A2 Granules with filamentous coatings |
10/02/2003 | WO2003080826A1 Saccharomyces cerevisiae yeast strain with improved phytase activity |
10/02/2003 | WO2003080825A2 Further bmp-2 inducible kinases and the uses thereof |
10/02/2003 | WO2003080809A2 Methods and compositions for using zinc finger endonucleases to enhance homologous recombination |
10/02/2003 | WO2003080805A2 Kinases and phosphatases |
10/02/2003 | WO2003080804A2 Regulation of ins(3456)p4 signalling by a reversible kinase/phosphatase and methods and compositions related thereto |
10/02/2003 | WO2003080802A2 Nucleic acid constructs and methods for producing altered seed oil compositions |
10/02/2003 | WO2003080796A2 Ordered biological nanostructures formed from chaperonin polypeptides |
10/02/2003 | WO2003080646A2 Modified plasminogen activator inhibitor type-1 and methods based thereon |
10/02/2003 | WO2003080638A2 Antisense iap nucleobase oligomers and uses thereof |
10/02/2003 | WO2003079977A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap |
10/02/2003 | WO2003079766A2 Generation of plants with altered oil content |
10/02/2003 | WO2003052087A3 Regulation of human short chain dehydrogenase/-reductase |
10/02/2003 | WO2003033713A8 Production of oil with higher erucic acid content |
10/02/2003 | WO2003016535A3 Novel amylases and uses thereof |
10/02/2003 | WO2003015692A3 Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same |
10/02/2003 | WO2003007793A3 Compositions, methods, and kits related to treating and diagnosing hypertension |
10/02/2003 | WO2003000901A8 Nucleic acids encoding protein kinases |
10/02/2003 | WO2002097040A3 Methods for the identification of inhibitors of pectin esterase expression or activity in plants |
10/02/2003 | WO2002079461A3 Type ii thioesterase from streptomyces coelicolor a3(2) and the coding sequence |
10/02/2003 | WO2002068597A3 Enzymes having alpha amylase activity and methods of use thereof |
10/02/2003 | WO2002061094A3 Microbiological method for producing l-carnitine |
10/02/2003 | WO2002057474A3 Processes for enhanced production of pantothenate |
10/02/2003 | WO2002045497A3 Transgenic mice containing dusp8 phosphatase gene disruptions |
10/02/2003 | WO2002044392A9 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence programmed and cell death in plants |
10/02/2003 | WO2002030940A3 Low molecular serine protease inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals |
10/02/2003 | WO2002007670A3 Intracellular delivery system for protein phosphatases |
10/02/2003 | WO2002000864A3 Histone acetyltransferase inhibitors and their use as insecticides |
10/02/2003 | WO2001090155A3 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses |
10/02/2003 | WO1999058707A3 Purified porcine kidney l-fucose kinase |
10/02/2003 | US20030188346 Methods for making plants tolerant to glyphosate and compositions thereof |
10/02/2003 | US20030188334 Magnesium chelatase |
10/02/2003 | US20030188328 Human heme-regulated initiation factor 2-alpha kinase |
10/02/2003 | US20030188327 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
10/02/2003 | US20030188325 Genetically engineered rodent cells comprising mutated regulatory erythroid kinase (REDK) gene for treatment of blood disorders such as anemia; animal models |
10/02/2003 | US20030187243 Novel expression-regulating sequences and expression products in the field of filamentous fungi |
10/02/2003 | US20030187242 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/02/2003 | US20030187240 Nuclease resistant |
10/02/2003 | US20030187239 Comprises nucleotide sequences coding membrane proteins for use as antiproliferative/antitumor/antiinflammatory agents; drug screening |
10/02/2003 | US20030187238 Comprises nucleotide sequences coding membrane proteins for use as antiproliferative/antitumor/antiinflammatory agents; drug screening |
10/02/2003 | US20030187230 Chimeric humanized monoclonal antibody for treating tumors and inflammation |
10/02/2003 | US20030187229 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/02/2003 | US20030187228 Chimeric humanized monoclonal antibody for treating tumors and inflammation |
10/02/2003 | US20030187220 Generating computer readable database comprising three-dimensional molecular structural cooridinates of flavin oxidureductase polypeptide; enzyme inhibitors; microbiocides |
10/02/2003 | US20030187218 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptides; cancer diagnosis |
10/02/2003 | US20030187215 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptides; cancer diagnosis |
10/02/2003 | US20030187214 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/02/2003 | US20030187212 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/02/2003 | US20030187206 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/02/2003 | US20030187197 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/02/2003 | US20030187196 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/02/2003 | US20030187195 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/02/2003 | US20030187194 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/02/2003 | US20030187193 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents |
10/02/2003 | US20030187192 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents |
10/02/2003 | US20030187191 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents |
10/02/2003 | US20030187190 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents |
10/02/2003 | US20030187189 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/02/2003 | US20030187056 Enzyme inhibitors; rolipram; antiinflammatory agents, bone disorders, respiratory system disorders, skin disorders |
10/02/2003 | US20030186881 Nucleotide sequences comprising complementary DNA codes for cyclin-dependent kinases, that control phosphorylation in cells, used in diagnosis and prophylaxis of diseases |
10/02/2003 | US20030186879 Nucleic acids that code for acylcoenzyme A; cholesterol acyltransferase (ACAT) required for viability protein (ARV1p), used to controlling lipid oil metabolism |
10/02/2003 | US20030186877 Helical peptidomimetics |